“…8 Hz),159.5,159.5,148.5,148.3,141.7,132.9 (d,J = 8.6 Hz), 130.4 (d, J = 1. 3 Hz),124.5 (d,J = 3.8 Hz),123.3,117.1 (d,J = 21.5 Hz),116.9,115.7 (d,J = 10.4 Hz),109.8,35.0,31.8;19 F NMR (471 MHz, CDCl 3 ) δ −110.19 (d, J = 6.1 Hz); IR (neat/cm −1 ) 3077, 2962,2907,2869,1623,1613,1588,1546,1482,1460,1341,1274,1223,1203,1111,1024,874,829,803,777,749,704,659 2-(2-Fluorophenyl)pyrimidine (1l). A suspension of 2-bromopyrimidine (1 mmol, 157 mg, 1.0 equiv) and (2-fluorophenyl)boronic acid (1.1 mmol, 154 mg, 1.1 equiv), Pd(PPh 3 ) 4 (0.05 mmol, 57 mg, 5 mol %), Na 2 CO 3 (2 mmol, 210 mg, 2.0 equiv), EtOH (3 mL), deionic water (3 mL), N,N-dimethylacetamide (5 mL) was stirred at 120 °C under nitrogen in a sealed Shlenck tube for 18 h. After finished, the mixture was extracted with ethyl acetate (5 mL × 3), the combined organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, purified through Silica gel chromatography (PE/EA = 10/1), which afforded the desired product 1l in colorless oil (150 mg, 86%); 1 H NMR (400 MHz, CDCl 3 ) δ 8.78 (d, J = 4.9 Hz, 2H), 7.99 (td, J = 7.8, 1.7 Hz, 1H), 7.44−7.31 (m, 1H), 7.20 (d, J = 7.6 Hz, 1H), 7.12 (d, J = 7.9 Hz, 1H); 19 1,116.8 (d,J = 22.5 Hz); IR (neat/cm −1 ) 3045,…”